跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 86 条关于
“MidCap”
全部
86
临床试验
52
药物
20
机构
3
资讯
11
10个月前
Tissue Regenix Faces Urgent Funding Crisis as Regenerative Medicine Company Seeks £5M to Avoid Insolvency
上个月
Insmed's Brinsupri Launch Pace Raises Concerns Despite Strong Q2 Prescription Trends
去年
Low Incidence of SARS-CoV-2 Resistance to Paxlovid Observed in Clinical Trials
去年
Alpha Tau Secures MDSAP Certification for Alpha DaRT Cancer Therapy Manufacturing Facility
去年
Nirsevimab Resistance Rare in RSV Breakthrough Cases, Study Finds
去年
FDA Approves Orlynvah, a New Oral Antibiotic for Complicated UTIs
去年
Nirsevimab Shows Promise in Protecting Infants Against RSV Infection
2年前
Nirsevimab Shows Promise in Preventing RSV in Infants and Immunocompromised Children
去年
Levofloxacin Shows Promise in Preventing Drug-Resistant TB in Household Contacts
去年
Shorter Bedaquiline Regimens Show Sustained Efficacy Against Rifampicin-Resistant TB
第 1 页,共 2 页
上一页
下一页